UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 146

Sortiert nach

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Breast cancer research : BCR, 2016-03, Vol.18 (1), p.33-33, Article 33

2016

Volltextzugriff (PDF)

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Nature communications, 2020-11, Vol.11 (1), p.5679-5679, Article 5679

2020

Volltextzugriff (PDF)

The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017

Frontiers in oncology, 2020-05, Vol.10, p.650-650

2020

Volltextzugriff (PDF)

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Oncogene, 2021-03, Vol.40 (12), p.2323-2334

2021

Volltextzugriff (PDF)

Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study

Cancer medicine (Malden, MA), 2020-03, Vol.9 (5), p.1922-1936

2020

Volltextzugriff (PDF)

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Clinical cancer research, 2022-07, Vol.28 (13), p.2807-2817

2022

Volltextzugriff (PDF)

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

Clinical cancer research, 2016-10, Vol.22 (19), p.4859-4869

2016

Volltextzugriff (PDF)

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

BMC cancer, 2018-01, Vol.18 (1), p.74-11, Article 74

2018

Volltextzugriff (PDF)

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

Cancer, 2019-07, Vol.125 (13), p.2185-2193

2019

Volltextzugriff (PDF)

No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma

Journal of surgical oncology, 2018-11, Vol.118 (6), p.928-935

2018

Volltextzugriff (PDF)

LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

Molecular cancer, 2020-05, Vol.19 (1), p.87-87, Article 87

2020

Volltextzugriff (PDF)

MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer

Clinical cancer research, 2013-03, Vol.19 (6), p.1389-1399

2013

Volltextzugriff (PDF)

The effect of laterality and primary tumor site on cancer-specific mortality in breast cancer: a SEER population-based study

PloS one, 2014-04, Vol.9 (4), p.e94815-e94815

2014

Volltextzugriff (PDF)

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

The lancet oncology, 2024-02, Vol.25 (2), p.184-197

2024

Volltextzugriff (PDF)

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

Science advances, 2019-03, Vol.5 (3), p.eaat9820-eaat9820

2019

Volltextzugriff (PDF)

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Breast cancer research and treatment, 2021, Vol.185 (2), p.371-380

2021

Volltextzugriff (PDF)

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Breast cancer research : BCR, 2007-01, Vol.9 (6), p.R76-R76, Article R76

2007

Volltextzugriff (PDF)

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Breast cancer research and treatment, 2012-02, Vol.131 (3), p.837-848

2012

Volltextzugriff (PDF)

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer

Molecular therapy. Oncolytics, 2022-03, Vol.24, p.624-635

2022

Volltextzugriff (PDF)

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359231225032-17588359231225032

2024

Volltextzugriff (PDF)

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy

PloS one, 2014-12, Vol.9 (12), p.e114646-e114646

2014

Volltextzugriff (PDF)

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer

Journal for immunotherapy of cancer, 2021-10, Vol.9 (10), p.e003371

2021

Volltextzugriff (PDF)

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

Proteomics (Weinheim), 2006-06, Vol.6 (11), p.3352-3368

2006

Volltextzugriff (PDF)

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers

Molecular therapy, 2021-07, Vol.29 (7), p.2350-2365

2021

Volltextzugriff (PDF)

Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery

Frontiers in oncology, 2021-08, Vol.11, p.690658-690658

2021

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(135)

Publikationsform

Artikel
(146)

Sprache

Englisch
(114)
Chinesisch
(33)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Dual Characteristics of Novel HER2 Kinase Domain Mutations in Response to HER2-Targeted Therapies in Human Breast Cancer

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

Concurrent neoadjuvant chemotherapy and estrogen deprivation in patients with estrogen receptor–positive, human epidermal growth factor receptor 2–negative breast cancer (CBCSG‐036): A randomized, controlled, multicenter trial

No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma

LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer

MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer

The effect of laterality and primary tumor site on cancer-specific mortality in breast cancer: a SEER population-based study

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradation

Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variations

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer

Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer

Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial

ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy

Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer

Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry

Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers

Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery

Suchergebnisse filtern